WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New DDDs

List of new DDDs decided at the latest meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the DDDs should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the new DDDs will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list.

ATC codeATC level name (INN/generic name)DDDUnit Adm.routeDeadline for objection to temporary DDDs Implementation in ATC/DDD index if no objection is received
A06AH03naloxegol25mgO01.02.20162017
A10AE56insulin degludec and liraglutide401)P01.02.20162017
A16AB12elosulfase alfa20mgP01.02.20162017
B01AC25cangrelor50mgP01.02.20162017
B01AF03edoxaban60mgO01.02.20162017
B01AX01defibrotide1.75gP01.02.20162017
C10AX13evolocumab14mgP01.02.20162017
C10AX14alirocumab5.4mgP01.02.20162017
G03XB51mifepristone, combinations0.22)O01.02.20162017
J01XE03furazidin0.3gO01.02.20162017
J01XX11tedizolid0.2gO,P01.02.20162017
J04AB05rifapentine0.11gO01.02.20162017
L04AA32apremilast60mgO01.02.20162017
L04AC10secukinumab10mgP01.02.20162017
M09AX03ataluren2.8gO01.02.20162017
N04BD03safinamide75mgO01.02.20162017
N05AX14iloperidone18mgO01.02.20162017
V03AE07calcium acetate6gO01.02.20162017
V03AE08ferric citrate6gO01.02.20162017
1) Refers to insulin degludec
2) The DDD for the combination package with mifepristone tabl and misoprostol vaginal tabl refers to mifepristone.

Last updated: 2015-12-18